Peptide-Modified Liposomes

Liposomal drug delivery systems have evolved significantly through the incorporation of functional peptides that enhance cellular uptake, tissue targeting, and intracellular trafficking. Peptide-modified liposomes combine the biocompatibility and encapsulation capacity of phospholipid bilayers with the molecular recognition properties of short peptide sequences, enabling precise delivery of therapeutic payloads to specific cell populations.

Cell-Penetrating Peptides

Cell-penetrating peptides (CPPs) such as TAT, penetratin, and transportan are cationic or amphipathic sequences typically 5-30 amino acids in length. When conjugated to liposomal surfaces, CPPs facilitate direct translocation across cell membranes through energy-independent mechanisms or macropinocytosis. Studies demonstrate that CPP-functionalized liposomes achieve 10-50 fold improvements in cellular uptake compared to unmodified counterparts, with transduction efficiencies reaching 80-95% in vitro.

RGD Targeting

The integrin-binding tripeptide Arg-Gly-Asp (RGD) exploits overexpression of alpha-v-beta-3 integrins on tumor vasculature and various cancer cell lines. RGD-liposomes exhibit preferential accumulation in solid tumors through active targeting, with tumor-to-tissue ratios improving 3-8 fold over passive accumulation alone. Cyclic RGD variants (c(RGDfK)) demonstrate enhanced binding affinity (K_d in low nanomolar range) compared to linear counterparts due to conformational pre-organization.

Endosomal Escape

A critical challenge for liposomal delivery is endosomal entrapment following receptor-mediated endocytosis. Fusogenic peptides such as the HA2 sequence from influenza hemagglutinin undergo pH-dependent conformational changes at endosomal pH (5.0-6.0), disrupting membrane integrity and releasing cargo into the cytoplasm. Incorporation of these peptides into liposome formulations can increase cytoplasmic delivery by 5-20 fold, dramatically improving bioavailability of nucleic acid therapeutics and protein payloads.

Formulation Considerations

Peptide conjugation to liposomes is achieved through NHS-ester coupling, maleimide-thiol chemistry, or click chemistry approaches. Lipid composition influences peptide orientation and surface density, with optimal PEG spacer lengths of 2000-3500 Da balancing stealth properties with ligand accessibility. Current research focuses on dual-functionalized systems combining CPPs with targeting ligands for sequential targeting and internalization.